Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-17

Clinical Trial Update: Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH) [Phase 1, Phase 2]

View source ↗

Summary

This is a phase 1/2 clinical trial evaluating daily aspirin versus split dosing in high-risk pregnancies to prevent preterm birth and preeclampsia. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Preterm Birth, Preeclampsia | Phase 1, Phase 2 | Status: RECRUITING